วันอังคารที่ 28 กรกฎาคม พ.ศ. 2569

Acetaminophen (Paracetamol) Poisoning (T39.1X1A / T39.1X2A)

Acetaminophen (Paracetamol) Poisoning (T39.1X1A / T39.1X2A)

Lab
Serum Acetaminophen Level (draw 4 hours after single acute ingestion; repeat if indicated)
CBC, BUN, Cr, electrolytes, LFTs, PT/INR, POCT Glucose
ABG/VBG, Serum Lactate (massive overdose or hepatic failure)
β-hCG (women of childbearing age)
• Toxicology screen (co-ingestion suspected)

 

Investigation
• ECG (co-ingestion or altered mental status)
• Continuous Cardiac Monitor (massive overdose or unstable patient)
Plot serum acetaminophen level on Rumack-Matthew Nomogram (single acute ingestion with known time)

 

ER Treatment
GI Decontamination
Activated Charcoal 1 g/kg (max 50 g) within 2 hours of ingestion (up to 4 hours for massive ingestion or sustained-release formulation if airway protected)

N-acetylcysteine (NAC)
Start immediately if:

  • Serum acetaminophen level above treatment line on Rumack-Matthew Nomogram
  • Unknown time of ingestion
  • Presentation >8 hours after potentially toxic ingestion
  • Delayed laboratory result
  • Repeated supratherapeutic ingestion meeting treatment criteria
  • Evidence of hepatic injury regardless of serum level

IV NAC (Preferred)
Two-bag regimen

  • 200 mg/kg over 4 hr
  • Then 100 mg/kg over 16 hr
  • Total = 300 mg/kg over 20 hr

 

Continue NAC beyond standard duration if
• Detectable acetaminophen concentration persists
• AST/ALT rising
• INR elevated
• Hepatic failure persists

 

Admission
• All patients receiving IV NAC
• Delayed presentation (>8 hr)
• Hepatotoxicity or acute liver failure
• Massive overdose (>30 g or >500 mg/kg)
• Altered mental status or co-ingestion requiring monitoring
• Psychiatric evaluation for intentional overdose

ไม่มีความคิดเห็น:

แสดงความคิดเห็น